MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Antipsychotic Prescriptions Among Nursing Home Residents with Parkinson’s Disease in the End-of-Life Period

    S. Berman, A. Willis, W. Aamodt (Philadelphia, USA)

    Objective: To determine whether antipsychotic prescriptions differ between community-dwelling and nursing home residents with PD in the last 6 months of life. Background: Most antipsychotics…
  • 2024 International Congress

    Association between statin use and mortality in Parkinson’s disease

    M. Park, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)

    Objective: To investigate whether usage of statin is associated with decreased mortality in Parkinson’s disease (PD). Background: Large-scale genome sequencing studies of PD have identified…
  • 2024 International Congress

    Writing rehabilitation in parkinson’s disease (pd) through a virtual workshop

    F. Echeverria, P. Sanchez Diaz, S. Revellini, G. Costa, G. Ziegler, S. Rodriguez Quiroga, T. Arakaki, N. Garretto (Buenos Aires, Argentina)

    Objective: Evaluate the effect of intensive writing training through a virtual workshop once a week and the potential influence in the quality of life in…
  • 2024 International Congress

    Effectiveness of Subthalamic nucleus (STN) Deep Brain Stimulation Surgery (DBS) in patients with Parkinson’s Disease: A Patient and Caregiver reported outcome

    S. Majumdar, S. Shee, S. Choudhury, J. Ganguly, P. Basu, N. Pandita, H. Kumar (Kolkata, India)

    Objective: We aim to assess the subjective impression on effectiveness and safety of Subthalamic nucleus Deep Brain Stimulation Surgery (STN-DBS) in patients with Parkinson’s Disease…
  • 2024 International Congress

    Pregnancy in Parkinson’s disease: Five cases

    C. Armas, Y. Núñez, G. Gushiken, C. Cosentino (Lima, Peru)

    Objective: To report additional cases to the literature of Parkinson’s disease (PD) and pregnant. Background: Pregnancy in PD is a relatively rare occurrence as PD…
  • 2024 International Congress

    Repurposing Anti-Gout Medications for the Treatment of Parkinson’s Disease

    R. Hughes, O. Bandmann, L. Ferraiuolo, H. Mortiboys (Sheffield, United Kingdom)

    Objective: To undertake a repurposing drug screen for Parkinson’s disease (PD) and further investigate the mechanism of action of top hits. To assess, in vivo,…
  • 2024 International Congress

    Case Report Increasing ‘On-time’ Using Mucuna pruriens Concomitantly with Traditional Levodopa/carbidopa Management

    T. Denne (United States, USA)

    Objective: Case study to see if concomitant use of the botanical Mucuna pruriens with traditional levodopa/carbidopa management could improve patient ‘off-time.’ Background: Mucuna pruriens is a pantropical legume…
  • 2024 International Congress

    The Protective Role of Lysosomal Damage Response in Preventing α-Synuclein Propagation

    K. Kakuda, K. Ikenaka, C. Aguirre, C. Choong, Y. Kimura, J. Doi, H. Mochizuki (Suita, Japan)

    Objective: The aim of this study was to investigate the mechanism by which the lysosomal damage response (LDR) defends against the escape of α-synuclein (αSyn)…
  • 2024 International Congress

    Pathological Mechanisms Associated with Atrazine-Induced Parkinson’s Disease Pathogenesis in Rat Model: The Rescue Role of Myricetin

    C. Ikeji, E. Farombi (Ibadan, Nigeria)

    Objective: This study aimed at investigating the mechanisms involved in the pathogenesis of Parkinson’s Disease in atrazine rat model of Parkinson’s Disease and the neuroprotective…
  • 2024 International Congress

    Studying digenic Parkinson’s disease in a stem cell model carrying mutant p.N409S in the GBA1 gene and the homozygous deletion of exon 3 PARK2

    C. Oleksy, Z. Hanss, F. Massart, G. Arena, I. Boussaad, R. Krüger (Belvaux, Luxembourg)

    Objective: We aim to study the combined effect of the GBA1 p.N409S mutation and a complete loss of Parkin based on a patient-based stem cell…
  • « Previous Page
  • 1
  • …
  • 481
  • 482
  • 483
  • 484
  • 485
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley